The lipoprotein-immune checkpoint axis: Linking cardiovascular toxicity and antitumor immunity during immune checkpoint therapy.
- DOI
- 10.1016/j.vph.2026.107719
- Published
- 2026 Nov 2
- Container
- Vascular pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.vph.2026.107719,
title = {The lipoprotein-immune checkpoint axis: Linking cardiovascular toxicity and antitumor immunity during immune checkpoint therapy.},
author = {Liang S and Wang X and Zhang J and Tao C and Gan W},
year = {2026},
journal = {Vascular pharmacology},
doi = {10.1016/j.vph.2026.107719},
url = {https://doi.org/10.1016/j.vph.2026.107719}
}RIS
TY - JOUR TI - The lipoprotein-immune checkpoint axis: Linking cardiovascular toxicity and antitumor immunity during immune checkpoint therapy. AU - Liang S AU - Wang X AU - Zhang J AU - Tao C AU - Gan W PY - 2026 JO - Vascular pharmacology DO - 10.1016/j.vph.2026.107719 UR - https://doi.org/10.1016/j.vph.2026.107719 ER -
APA
S, L., X, W., J, Z., C, T., & W, G. (2026). The lipoprotein-immune checkpoint axis: Linking cardiovascular toxicity and antitumor immunity during immune checkpoint therapy.. Vascular pharmacology. https://doi.org/10.1016/j.vph.2026.107719
Source records
- pubmed · retrieved 2026-11-10T10:34:14.667Z